Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in healthy subjects aged 3 to 17 years old: A phase III, open label, single-arm study - Chang, Chia-Yuan; Cho, Ching-Yi; Lai, Chou-Cheng; Lu, Chun-Yi; Chang, Luan-Yin; Hung, Miao-Chiu; Huang, Li-Min; Wu, Keh-Gong (Vaccine, 2020)
Keywords: Adolescent; Age; Allergy and Immunology; Antibodies; Antibodies, Viral - blood; Child; Child, Preschool; Children; Guillain-Barre syndrome; Healthy Volunteers; hemagglutination; Hemagglutination inhibition; Hemagglutination Inhibition Tests; Humans; Immunization; Immunogenicity; Immunogenicity, Vaccine; Influenza; Influenza B; Influenza B virus - immunology; influenza vaccines; Influenza Vaccines - adverse effects; Influenza Vaccines - immunology; Influenza, Human - prevention & control; Quadrivalent; Safety; Seasons; Seroconversion; Split viron vaccine; Taiwan; vaccination; Vaccines; Vaccines, Inactivated - adverse effects; Vaccines, Inactivated - immunology; Taiwan; United States--US; Safety; Quadrivalent; Children; Immunogenicity; Split viron vaccine; Influenza